Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance

por Gonzalez de Castro, D, Clarke, P A, Al-Lazikani, B, Workman, P
Publicado 2013

A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens

por Gonzalez de Castro, D, Angulo, B, Gomez, B, Mair, D, Martinez, R, Suarez-Gauthier, A, Shieh, F, Velez, M, Brophy, V H, Lawrence, H J, Lopez-Rios, F
Publicado 2012

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial

por Sclafani, F., Chau, I., Cunningham, D., Peckitt, C., Lampis, A., Hahne, J.C., Braconi, C., Tabernero, J., Glimelius, B., Cervantes, A., Begum, R., Gonzalez De Castro, D., Hulkki Wilson, S., Eltahir, Z., Wotherspoon, A., Tait, D., Brown, G., Oates, J., Valeri, N.
Publicado 2015

Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial

por Strefford, JC, Kadalayil, L, Forster, J, Rose-Zerilli, MJJ, Parker, A, Lin, TT, Heppel, N, Norris, K, Gardiner, A, Davies, Z, Gonzalez de Castro, D, Else, M, Steele, AJ, Parker, H, Stankovic, T, Pepper, C, Fegan, C, Baird, D, Collins, A, Catovsky, D, Oscier, DG
Publicado 2015